FMR1 and renal cell carcinoma: Our future research will integrate RNA–protein interactome mapping (e.g., CLIP‐seq or RIP‐seq) with complementary proteomic and transcriptome analyses to comprehensively delineate FMR1‐associated networks in RCC.